WallStSmart

PetMed Express Inc (PETS)vsPOMDOCTOR LIMITED American Depositary Shares (POM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

POMDOCTOR LIMITED American Depositary Shares generates 137% more annual revenue ($399.92M vs $168.86M). PETS leads profitability with a -17.3% profit margin vs -53.2%. PETS earns a higher WallStSmart Score of 43/100 (D).

PETS

Hold

43

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.3Quality: 5.0
Piotroski: 2/9Altman Z: 1.29

POM

Avoid

28

out of 100

Grade: F

Growth: 6.7Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 3/9Altman Z: -33.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PETSUndervalued (+70.8%)

Margin of Safety

+70.8%

Fair Value

$10.16

Current Price

$1.65

$8.51 discount

UndervaluedFair: $10.16Overvalued

Intrinsic value data unavailable for POM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PETS3 strengths · Avg: 9.3/10
EPS GrowthGrowth
266.7%10/10

Earnings expanding 266.7% YoY

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

POM2 strengths · Avg: 9.0/10
Debt/EquityHealth
-1.0010/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
17.2%8/10

17.2% revenue growth

Areas to Watch

PETS4 concerns · Avg: 3.0/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

Market CapQuality
$39.24M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-100.6%2/10

ROE of -100.6% — below average capital efficiency

POM4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$6.19M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : PETS

The strongest argument for PETS centers on EPS Growth, Debt/Equity, Price/Book.

Bull Case : POM

The strongest argument for POM centers on Debt/Equity, Revenue Growth. Revenue growth of 17.2% demonstrates continued momentum.

Bear Case : PETS

The primary concerns for PETS are PEG Ratio, Market Cap, Piotroski F-Score.

Bear Case : POM

The primary concerns for POM are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

PETS profiles as a turnaround stock while POM is a growth play — different risk/reward profiles.

POM is growing revenue faster at 17.2% — sustainability is the question.

PETS generates stronger free cash flow (-8M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PETS scores higher overall (43/100 vs 28/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

PetMed Express Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

PetMed Express, Inc., doing business as 1-800-PetMeds, is a pet pharmacy in the United States. The company is headquartered in Delray Beach, Florida.

POMDOCTOR LIMITED American Depositary Shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.

Visit Website →

Want to dig deeper into these stocks?